1. Home
  2. WLDN vs CRVS Comparison

WLDN vs CRVS Comparison

Compare WLDN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$87.00

Market Cap

1.3B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.02

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
CRVS
Founded
1964
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
WLDN
CRVS
Price
$87.00
$14.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$114.50
$30.17
AVG Volume (30 Days)
201.9K
645.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
48.04
EPS
2.13
N/A
Revenue
$273,352,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.05
N/A
P/E Ratio
$40.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$64.67
$5.64
52 Week High
$137.00
$26.95

Technical Indicators

Market Signals
Indicator
WLDN
CRVS
Relative Strength Index (RSI) 59.41 47.02
Support Level $72.52 $14.07
Resistance Level $88.72 $16.66
Average True Range (ATR) 2.85 0.61
MACD -0.15 -0.07
Stochastic Oscillator 74.81 18.41

Price Performance

Historical Comparison
WLDN
CRVS

About WLDN Willdan Group Inc.

Willdan Group Inc is a technical services company focused on energy and infrastructure solutions. The company's solutions include energy planning and analytics, consulting, software, public finance, engineering, and program implementation. It operates through two segments: i) Energy segment: It provides specialized, comprehensive energy solutions to businesses, utilities, state agencies, municipalities, and non-profit organizations. ii) Engineering & Consulting: It provides civil engineering and construction management, building and safety services, city engineering and planning support, civil design, geotechnical services, and material testing. The majority of revenue is derived from the Energy segment. Geographically, all of the company's revenue is generated from the United States.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: